All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

16

Reset

16 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ZasocitinibTAK- 279, NDI-034858Phase 317 trials

    Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease

  • ElriterceptTAK-226, KER-050Phase 36 trials

    Takeda · Myelodysplastic Syndromes, Myelofibrosis, Anemia

  • TDVTAK-003, Tetravalent Dengue VaccinePhase 35 trials

    Takeda · Dengue Fever, Healthy Volunteers

  • MezagitamabTAK-079Phase 34 trials

    Takeda · Immune Thrombocytopenic Purpura (ITP), Antibody-Mediated Rejection (AMR), Kidney Disease

  • TAK-360Phase 34 trials

    Takeda · Narcolepsy Type 1, Idiopathic Hypersomnia, Narcolepsy Type 2

  • FazirsiranTAK-999, ARO-AATPhase 33 trials

    Takeda · Alpha1-Antitrypsin Deficiency

  • TAK-755rADAMTS13, recombinant ADAMTS13Phase 33 trials

    Takeda · Thrombotic Thrombocytopenic Purpura (TTP), Acute Ischemic Stroke

  • TAK-771Phase 32 trials

    Takeda · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Primary Immunodeficiency Diseases (PID)

  • TAK-330Phase 31 trial

    Takeda · Coagulation Disorder

  • TAK-928Phase 31 trial

    Takeda · IO Resistant Squamous and Nonsquamous NSCLC

  • TAK-007Phase 21 trial

    Takeda · Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

  • TAK-101Phase 21 trial

    Takeda · Celiac Disease

  • TAK-188Phase 21 trial

    Takeda · Advanced or Metastatic Solid Tumors

  • TAK-341MEDI1341Phase 21 trial

    Takeda · Multiple System Atrophy

  • TAK-411Hypersialylated Immune Globulin GPhase 21 trial

    Takeda · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • TAK-505Phase 21 trial

    Takeda · Malignant Solid Tumors

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.